Please ensure Javascript is enabled for purposes of website accessibility

pharmaceutical

Attorney Ben Crump, at right, stands with members of Henrietta Lacks' family at a May 2022 news conference. From second right is Lacks' son, Lawrence Lacks, and her grandsons, Alfred Carter Jr. and Ron Lacks. (The Daily Record file photo)
Mar 16, 2026

Family of Henrietta Lacks reaches third Big Pharma settlement

The estate of Henrietta Lacks, the Black woman from Baltimore whose cancer cells fueled scientific discovery and profit for Big Pharma, has reached a settlement with a third pharmaceutical company.

Attorney Ben Crump, at right, stands with members of Henrietta Lacks' family at a May 2022 news conference. From second right is Lacks' son, Lawrence Lacks, and her grandsons, Alfred Carter Jr. and Ron Lacks. (The Daily Record file photo)
Mar 3, 2026

Family of Baltimore’s Henrietta Lacks settles unjust enrichment lawsuit

The family of Henrietta Lacks, a Black Baltimorean whose cells contributed to major scientific breakthroughs, has reached another settlement with a pharmaceutical giant.

Former drug company executive Martin Shkreli arrives at U.S. District Court in his securities fraud trial in New York City, August 2, 2017. (REUTERS/Amr Alfiky/File Photo)
Feb 3, 2026

Ex-pharma exec countersues over unique Wu-Tang Clan album

Martin Shkreli, the convicted former pharmaceutical executive, countersued a digital art collective that paid $4 million for a one-of-a-kind album by the hip-hop group Wu-Tang Clan.

A U.S. flag stands next to the AstraZeneca logo during a signing event for documents related to a manufacturing site investment at the Meridian International Center in Washington, D.C., July 21, 2025. (REUTERS file/Umit Bektas)
Nov 21, 2025

AstraZeneca to invest $2B in MD as part of manufacturing push

AstraZeneca will invest $2B to expand biologics manufacturing in Frederick and build a facility in Gaithersburg, creating hundreds of jobs.

The Food and Drug Administration seal is seen at the Hubert Humphrey Building Auditorium in Washington, April 22, 2025. (AP Photo/Jose Luis Magana, File)
Nov 3, 2025

FDA’s top drug regulator resigns after federal officials probe ‘serious concerns’

FDA drug center head George Tidmarsh resigned as officials probed serious misconduct claims tied to a lawsuit from Aurinia Pharmaceuticals.

Gov. Wes Moore defended a new tax on information technology and data services saying it wouldn't limit the state's ability to attract and grow those industries in the state. (The Daily Record photo/Jack Hogan)
May 22, 2025

SJ Incorporation to open facility in Western Maryland

SJ Incorporation will open a new 35,000-square-foot medicine production facility at Fort Ritchie in Western Maryland.

IRA is forcing cuts to drug research
May 12, 2023

IRA is forcing cuts to drug research

President Joe Biden’s Inflation Reduction Act is just 8 months old. It hasn’t yet slain inflation. But it’s already gutting drug research and development. The law gives Medicare the power […]

The primary contributor to the majority of overdose deaths in Maryland involves some form of opioids. (Photo by Patrick Sison, AP)
Nov 3, 2021

Drug companies win in opioid crisis lawsuit

A California judge has ruled for top drug manufacturers as local governments seek billions of dollars to cover their costs from the nation’s opioid epidemic.

U.S. Sen. Ben Cardin, D-Md, left, U.S. Rep. David Trone, D-6th-Md., center, and Seth Lederman, Tonic CEO, chat in a lab area of the Tonix Pharmaceuticals facility after a ribbon cutting ceremony Oct. 18, 2021, in Frederick. Tonix Pharmaceuticals officially has a research and development center for infectious diseases — and it’s located in Frederick, right down the road from the city’s municipal airport. (Bill Green/The Frederick News-Post via AP)
Oct 25, 2021

Infectious disease research center opens in Frederick, with eye on future pandemics

Tonix Pharmaceuticals officially has a research and development center for infectious diseases in Frederick.

Despite COVID, an Easton pharmaceuticals facility added 156 workers, more space
Jul 28, 2021

Despite COVID, an Easton pharmaceuticals facility added 156 workers, more space

As Aphena Pharma Solutions worked to grow its footprint in both Maryland and Tennessee, it also had to navigate the challenges of the pandemic.

The primary contributor to the majority of overdose deaths in Maryland involves some form of opioids. (Photo by Patrick Sison, AP)
Jun 28, 2021

Johnson & Johnson to pay $230M to settle New York opioid claim

Johnson & Johnson has agreed to pay $230 million to New York state to settle claims that the pharmaceutical giant helped fuel the opioid crisis.

Kevin Kamenetz
Jan 8, 2018

Baltimore County to file federal lawsuit against opioid manufacturers

Baltimore County is poised to become the second Maryland jurisdiction to sue pharmaceutical manufacturers and distributors of opioids, alleging the industry pressured doctors to over-prescribe drugs and misrepresented the risk […]

Networking Calendar

Submit an entry for the business calendar